Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof

Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof

US Patent 12173289 · Granted Dec 24, 2024

Estimated economic value: $122,375,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
Short interfering nucleic acid (siNA) compositions2025
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and me2025
Coagulation factor V (F5) iRNA compositions and methods of use thereof2025
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof2025
PCSK9 iRNA compositions and methods of use thereof2025
PCSK9 iRNA compositions and methods of use thereof2025
Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods o2025
Ketohexokinase (KHK) iRNA compositions and methods of use thereof2025
Extrahepatic delivery2025
Extrahepatic delivery2025
Extrahepatic delivery2025